shipment_ID,catalog_ID,Formula,stereochemistry,sample_MW,purity,PO,Salt_Name,Salt_ratio,MW_salt,volume(uL),concentration(mM),plate_ID,well,SMILES,Name,Batch ID
Z734687642,Z734687642,C20H18ClN3O,Achiral,351.829,100,200415-FTE / COVID-19,,,0,4,100,1181202-Y4-29,05_A,ClC=1C=CC=C(C1)N2CCN(CC2)C(=O)C=3C=NC=C4C=CC=CC34,4-[4-(3-chlorophenyl)piperazine-1-carbonyl]isoquinoline,H2764130
Z4763834269,Z4763834269,C19H15ClN2O3,Racemic or presumed racemic or meso,354.787,100,200415-FTE / COVID-19,,,0,4,100,1181202-Y4-29,05_B,ClC=1C=CC=2OCCC(C(=O)NC3=CNC(=O)C=4C=CC=CC34)C2C1,"6-chloro-N-(1-oxo-1,2-dihydroisoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",H2751271
Z4618924237,Z4618924237,C23H22N6O2,Achiral,414.459,91.23,200415-FTE / COVID-19,,,0,4,100,1181202-Y4-29,05_C,CCC(=O)NC=1C=CC(=CC1)N(CC=2C=CC=CC2)C(=O)NN3N=NC=4C=CC=CC34,"N-(4-{[(1H-1,2,3-benzotriazol-1-yl)carbamoyl](benzyl)amino}phenyl)propanamide",H2756882
Z4661830648,Z4661830648,C18H13ClN2O2,Racemic or presumed racemic or meso,324.761,98.97,200415-FTE / COVID-19,,,0,4,100,1181202-Y4-29,05_D,ClC=1C=CC=C2C(COC21)C(=O)NC=3C=NC=C4C=CC=CC34,"7-chloro-N-(isoquinolin-4-yl)-2,3-dihydro-1-benzofuran-3-carboxamide",H2756863
Z4765682202,Z4765682202,C21H20ClN3O2,Racemic or presumed racemic or meso,381.855,100,200415-FTE / COVID-19,,,0,4,100,1181202-Y4-29,05_E,CC1CN(CCN1C=2C=CC=C(Cl)C2)C(=O)C3=CC(=O)NC=4C=CC=CC34,"4-[4-(3-chlorophenyl)-3-methylpiperazine-1-carbonyl]-1,2-dihydroquinolin-2-one",H2757857
Z4763834270,Z4763834270,C22H19N3OS,Achiral,373.470,98.88,200415-FTE / COVID-19,,,0,4,100,1181202-Y4-29,05_F,CC=1C=CC(=CC1)N(CC2=CSC=N2)C(=O)CC=3C=NC=C4C=CC=CC34,"2-(isoquinolin-4-yl)-N-(4-methylphenyl)-N-[(1,3-thiazol-4-yl)methyl]acetamide",H2758976
Z4765682194,Z4765682194,C19H15ClN2O2,Achiral,338.787,100,200415-FTE / COVID-19,,,0,4,100,1181202-Y4-29,05_G,ClC=1C=CC=2OCCN(C(=O)CC=3C=NC=C4C=CC=CC34)C2C1,"1-(6-chloro-3,4-dihydro-2H-1,4-benzoxazin-4-yl)-2-(isoquinolin-4-yl)ethan-1-one",H2757619
Z1892658668,Z1892658668,C19H14BrN3O2,Racemic or presumed racemic or meso,396.237,100,200415-FTE / COVID-19,,,0,4,100,1181202-Y4-29,05_H,BrC=1C=CC=2NC(=O)CC(C(=O)NC=3C=NC=C4C=CC=CC34)C2C1,"6-bromo-N-(isoquinolin-4-yl)-2-oxo-1,2,3,4-tetrahydroquinoline-4-carboxamide",H2757662
